SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
54 hedge funds and large institutions have $151M invested in Sienna Biopharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
1.24%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
26
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$2.27M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.65M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.12M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$996K |
| 5 |
BlackRock
New York
|
+$443K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| $8.4K | – | – | – |
|
52
Bank of Montreal
Toronto,
Ontario, Canada
| $2K | -$2.6K | -138 | -57% |
|
53
Daiwa Securities Group
Tokyo,
Japan
| $2K | – | – | – |
|
|
IA
54
IFP Advisors
Tampa,
Florida
| – | -$2.74M | -180,552 | Closed |
|
|
AG
55
Artal Group
Luxembourg
| – | -$1.5M | -99,000 | Closed |
|
56
Alyeska Investment Group
Chicago,
Illinois
| – | -$421K | -27,730 | Closed |
|
|
ACM
57
Asymmetry Capital Management
San Francisco,
California
| – | -$372K | -24,516 | Closed |
|
|
PCM
58
Prelude Capital Management
New York
| – | -$372K | -24,516 | Closed |
|
59
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$203K | -13,343 | Closed |
|
|
PIA
60
Piedmont Investment Advisors
Durham,
North Carolina
| – | -$4K | -268 | Closed |
|